 |
|
|
| |
HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 48 Subgroup Analysis
|
| |
| |
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
J Feinberg,1 JP Lalezari,2 M Martins,3 M Casapia,4 D Stock,5 C Llamoso,5 SR Joshi,5 GJ Hanna,6 M Lataillade 5 for the AI438011 study team
1University of Cincinnati, Cincinnati, OH, USA; 2. Quest Clinical Research, San Francisco, CA, USA; 3. Instituto Oulton, Cordoba, Argentina; 4. Asociacion Civil Selva Amazonica, Iquitos, Peru; 5. Bristol-Myers Squibb, Wallingford, CT, USA; 6. Bristol-Myers Squibb, Princeton, NJ, USA.
|
| |
|
|
|
|
|
